COMPANY
Microsurgical Innovations Inc
Funding and NIH signals
- NIH award NIH awarded $1.01M (STTR Phase II 5R42NS112066-03, continuation, notice May 19, 2026). NIH RePORTER 5R42NS112066-03 (May 19, 2026)
Evidence (1 event)
- May 19, 2026 · NIH RePORTER 5R42NS112066-03
Organization: MICROSURGICAL INNOVATIONS, INC.; City/State: SALT LAKE CITY, UT; Project number: 5R42NS112066-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-05-19; FY total cost (award amount): 1005546; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Tacrolimus-eluting nerve guidance conduit for enhanced regeneration in critical-sized peripheral nerve injuries; Organization type: Domestic For-Profits
- May 19, 2026 · NIH RePORTER 5R42NS112066-03